Hemolytic disease of the fetus and newborn and Rhesus alloimmunization in Latin American countries: a scoping review. [PDF]
Júnior MDC +5 more
europepmc +1 more source
Dual-biomarker strategy for prenatal prediction of ABO hemolytic disease: Maternal sVE-cadherin and anti-A/B IgG titer. [PDF]
Jiang DD, Li JW, Zhang XC.
europepmc +1 more source
343 Extreme Prematurity, Fetal Growth Restriction, and Non-Immune Erythroblastosis
Z Ghorishi, M Sherman, J Sherman
core +1 more source
Perinatal Hemolytic Disease Due to Anti-Jkb: A Case Report. [PDF]
Bandeira FM +5 more
europepmc +1 more source
Prenatal Exome Sequencing: When Does Diagnostic Yield Meet Clinical Utility? [PDF]
Carrer A +21 more
europepmc +1 more source
Ultrasound‐Guided Fetal Intravascular Transfusions for Severe Erythroblastosis, 1984–1993
L. de Crespigny +5 more
core +1 more source
Role of Placental Growth Factor in Predicting Birth Growth in Intrauterine Growth-Restricted Pregnancies and Its Correlation With Placental Histopathology: An Exploratory Study. [PDF]
Ashwini RC +4 more
europepmc +1 more source
ISOIMMUNIZATION: ITS ROLE IN TRANSFUSION REACTIONS AND IN FETAL ERYTHROBLASTOSIS
core +1 more source
Irregular antibodies in pregnancy during the universal anti-RHD prophylaxis era: a survey of Spanish Hospitals. [PDF]
Rodríguez-Aliberas M +28 more
europepmc +1 more source
Feasibility of Hemolytic Disease of the Fetus and Newborn Case Ascertainment and Assessing Its Impact on Prenatal and Postnatal Outcomes: Protocol for Observational Studies. [PDF]
Mensah NA +12 more
europepmc +1 more source

